137 related articles for article (PubMed ID: 26157678)
1. Clinical outcome of fiducial-less CyberKnife radiosurgery for stage I non-small cell lung cancer.
Jung IH; Song SY; Jung J; Cho B; Kwak J; Je HU; Choi W; Jung NH; Kim SS; Choi EK
Radiat Oncol J; 2015 Jun; 33(2):89-97. PubMed ID: 26157678
[TBL] [Abstract][Full Text] [Related]
2. Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer.
Temming S; Kocher M; Stoelben E; Hagmeyer L; Chang DH; Frank K; Hekmat K; Wolf J; Baus WW; Semrau R; Baues C; Marnitz S
Strahlenther Onkol; 2018 Feb; 194(2):91-97. PubMed ID: 28812120
[TBL] [Abstract][Full Text] [Related]
3. CyberKnife radiosurgery for stage I lung cancer: results at 36 months.
Brown WT; Wu X; Fayad F; Fowler JF; Amendola BE; García S; Han H; de la Zerda A; Bossart E; Huang Z; Schwade JG
Clin Lung Cancer; 2007 Sep; 8(8):488-92. PubMed ID: 17922973
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of stereotactic body radiotherapy using CyberKnife in Stage I primary lung tumor.
Awano N; Ikushima S; Izumo T; Tone M; Fukuda K; Miyamoto S; Bae Y; Kumasaka T; Terada Y; Furuhata Y; Nomura R; Sato K
Jpn J Clin Oncol; 2017 Oct; 47(10):969-975. PubMed ID: 28981731
[TBL] [Abstract][Full Text] [Related]
5. CyberKnife radiosurgery for malignant spinal tumors: characterization of well-suited patients.
Wowra B; Zausinger S; Drexler C; Kufeld M; Muacevic A; Staehler M; Tonn JC
Spine (Phila Pa 1976); 2008 Dec; 33(26):2929-34. PubMed ID: 19092627
[TBL] [Abstract][Full Text] [Related]
6. Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy.
Kelley KD; Benninghoff DL; Stein JS; Li JZ; Byrnes RT; Potters L; Knisely JP; Zinkin HD
Radiat Oncol; 2015 May; 10():120. PubMed ID: 26018408
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC).
Lischalk JW; Woo SM; Kataria S; Aghdam N; Paydar I; Repka MC; Anderson ED; Collins BT
J Radiat Oncol; 2016; 5(4):379-387. PubMed ID: 28018523
[TBL] [Abstract][Full Text] [Related]
8. Upfront radiosurgery plus targeted agents followed by active brain control using radiosurgery delays neurological death in non-small cell lung cancer with brain metastasis.
Lee SW; Kim YS; Sung SY; Kwak YK; Kang YN; Jang JS; Kang JH; Hong SH; Kim SJ; Jung SL
Clin Exp Metastasis; 2020 Apr; 37(2):353-363. PubMed ID: 32008137
[TBL] [Abstract][Full Text] [Related]
9. Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnife.
Brown WT; Wu X; Amendola B; Perman M; Han H; Fayad F; Garcia S; Lewin A; Abitbol A; de la Zerda A; Schwade JG
Cancer J; 2007; 13(2):87-94. PubMed ID: 17476136
[TBL] [Abstract][Full Text] [Related]
10. Is stereotactic body radiotherapy an alternative to surgery in early stage non small cell lung cancer?
Yaprak G; Ozan Seseogullari O; Dogan Akaslan B; Isik N
J BUON; 2019; 24(4):1619-1625. PubMed ID: 31646817
[TBL] [Abstract][Full Text] [Related]
11. CyberKnife
Oudin V; Salleron J; Marchesi V; Peiffert D; Khadige M; Faivre JC
J Thorac Dis; 2023 Sep; 15(9):4636-4647. PubMed ID: 37868838
[TBL] [Abstract][Full Text] [Related]
12. Predictive parameters of CyberKnife fiducial-less (XSight Lung) applicability for treatment of early non-small cell lung cancer: a single-center experience.
Bahig H; Campeau MP; Vu T; Doucet R; Béliveau Nadeau D; Fortin B; Roberge D; Lambert L; Carrier JF; Filion E
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):583-9. PubMed ID: 23953636
[TBL] [Abstract][Full Text] [Related]
13. Feasible Optimization of Stereotactic Ablative Radiotherapy Dose by Tumor Size for Stage I Non-small-cell Lung Cancer.
Lee S; Song SY; Kim SS; Choi W; Je HU; Back GM; Cho B; Jeong SY; Choi EK
Clin Lung Cancer; 2018 Mar; 19(2):e253-e261. PubMed ID: 29196082
[TBL] [Abstract][Full Text] [Related]
14. Fiducial marker placement via conventional or electromagnetic navigation bronchoscopy (ENB): an interdisciplinary approach to the curative management of lung cancer.
Hagmeyer L; Priegnitz C; Kocher M; Schilcher B; Budach W; Treml M; Stieglitz S; Randerath W
Clin Respir J; 2016 May; 10(3):291-7. PubMed ID: 25308297
[TBL] [Abstract][Full Text] [Related]
15. Intravascular Placement of Metallic Coils as Lung Tumor Markers for CyberKnife Stereotactic Radiation Therapy.
Karaman K; Dokdok AM; Karadeniz O; Ceylan C; Engin K
Korean J Radiol; 2015; 16(3):626-31. PubMed ID: 25995693
[TBL] [Abstract][Full Text] [Related]
16. Application of robotic stereotactic radiotherapy to peripheral stage I non-small cell lung cancer with curative intent.
Brown WT; Wu X; Fayad F; Fowler JF; García S; Monterroso MI; de la Zerda A; Schwade JG
Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):623-31. PubMed ID: 19682875
[TBL] [Abstract][Full Text] [Related]
17. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.
Senthi S; Lagerwaard FJ; Haasbeek CJ; Slotman BJ; Senan S
Lancet Oncol; 2012 Aug; 13(8):802-9. PubMed ID: 22727222
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer.
Nakajima K; Iwata H; Ogino H; Hattori Y; Hashimoto S; Toshito T; Hayashi K; Akita K; Baba F; Nakamae K; Mizoe JE; Shibamoto Y
Radiat Oncol; 2018 Oct; 13(1):199. PubMed ID: 30305125
[TBL] [Abstract][Full Text] [Related]
19. Impact of CyberKnife Radiosurgery on Median Overall Survival of Various Parameters in Patients with 1-12 Brain Metastases.
Murovic J; Ding V; Han SS; Adler JR; Chang SD
Cureus; 2017 Dec; 9(12):e1926. PubMed ID: 29464135
[TBL] [Abstract][Full Text] [Related]
20. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.
Sun B; Brooks ED; Komaki RU; Liao Z; Jeter MD; McAleer MF; Allen PK; Balter PA; Welsh JD; O'Reilly MS; Gomez D; Hahn SM; Roth JA; Mehran RJ; Heymach JV; Chang JY
Cancer; 2017 Aug; 123(16):3031-3039. PubMed ID: 28346656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
